Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

A brief filed with the U.S. Supreme Court yesterday urged the Justices to deny a petition to the Court contending the U.S.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

BEIJING -- China has highlighted its commitment to encouraging the long-term operation and development of foreign-funded ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

NEW DELHI: The Nifty Pharma index traded around 10:29AM(IST)on Thursday in an upbeat market. Mankind Pharma Ltd.(up 4.03 per ...

With the respiratory illness season starting up in earnest, Vicks has reclaimed the top Rx and over-the-counter (OTC) pharma ...